Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

LFCRLFCR
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in LIFECORE BIOMEDICAL INC

GOLDMAN SACHS GROUP INC holds 124,940 shares of LFCR (LIFECORE BIOMEDICAL INC), worth $655,935 as of 2026-Q2. The position was decreased (-25.8% shares). LFCR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$655,935

Current Shares

124,940

Total Value Change

+$365,489

Total Shares Change

+66,026

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
124,940
-25.8%
$655,9350.0%$5.25
0
2026-Q1
Increased
168,376
+79.8%
$626,3590.0%$3.72
37
2025-Q4
Increased
93,651
+69.2%
$766,0650.0%$8.18
37
2025-Q3
Increased
55,336
+37.2%
$407,2730.0%$7.36
21
2025-Q2
Decreased
40,339
-54.2%
$327,5530.0%$8.12
0
2025-Q1
Increased
87,998
+16.8%
$619,5060.0%$7.04
28
2024-Q4
Increased
75,351
+27.9%
$559,8580.0%$7.43
30
2024-Q3
Increased
58,914
+51.5%
$290,4460.0%$4.93
22

Other major holders of LFCR: BNP PARIBAS FINANCIAL MARKETS, Russell Investments Group, Ltd., DIMENSIONAL FUND ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used